COMMON STOCK AND WARRANTS. (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
Dec. 22, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
COMMON STOCK AND WARRANTS (Textual) | |||
Issued warrants to purchase aggregate | 5,500,000 | ||
Exercise price | $ 1.00 | $ 1.00 | |
Fair value adjustments for warrants | $ 977,000 | ||
Number of stock issued (in shares) | 3,137,392 | 838,213 | |
Number of stock issued, value | $ 3,670,413 | $ 2,056,966 | |
Fees paid | $ 65,838 | $ 36,951 | |
Maturity term | Dec. 15, 2019 | ||
Issued nonvoting common shares exercisable | 3,539,236 | ||
Non-Voting Common Stock [Member] | |||
COMMON STOCK AND WARRANTS (Textual) | |||
Issued nonvoting common shares exercisable | 896 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Issued nonvoting common shares exercisable. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. No definition available.
|
X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of cash paid for brokerage fees during the current period. This element is intended to represent the brokerage fees paid by and between financial industry participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of an employee stock purchase plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|